Technology
Health
Pharmaceutical

Bayer

$15.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.00 (-0.03%) Today
+$0.00 (0.03%) After Hours

Why Robinhood?

You can buy or sell Bayer and other stocks, options, ETFs, and crypto commission-free!

About

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. Read More The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany. BAYRY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
116,998
Headquarters
Leverkusen, Nordrhein-Westfalen
Founded
1952
Market Cap
56.64B
Price-Earnings Ratio
56.62
Dividend Yield
3.18
Average Volume
978.12K
High Today
$15.19
Low Today
$15.05
Open Price
$15.19
Volume
285.17K
52 Week High
$32.80
52 Week Low
$15.05

Collections

Technology
Health
Pharmaceutical
Healthcare
Materials
Advertising and Marketing
Therapy
Business Services

News

Seeking AlphaMay 23

Bayer teams up with the WHF Humanitarian Aid Program

Bayer (OTCPK:BAYRY) has announced a five-year partnership with the World Federation of Hemophilia (WFH) Humanitarian Aid Program, which will bring education, training, and Bayer's full portfolio of recombinant Factor VIII (rFVIII) treatments to healthcare professionals in more than 60 countries.

107
Yahoo FinanceMay 23

Bayer Judge Picks Mediator Ken Feinberg for Roundup Settlement Talks

(Bloomberg) -- A U.S. judge overseeing Roundup-cancer lawsuits against Bayer AG provisionally appointed high-profile mediator Ken Feinberg to lead settlement talks over the herbicide litigation, which has tanked the company’s stock since it acquired Monsanto almost a year ago.

10
Wall Street JournalMay 19

Bayer’s Roundup Problem Slashes Its Market Value

BERLIN—Less than a year after Bayer AG acquired Monsanto Co. and its Roundup weedkiller, the German company is stuck at what could be one of its darkest hours.

68
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.